In sur­prise, study sug­gests Covid mR­NA vac­cines may boost can­cer im­munother­a­py ef­fi­ca­cy

The mR­NA-based Covid vac­cines used by hun­dreds of mil­lions of peo­ple may pro­vide an un­ex­pect­ed ben­e­fit to some can­cer pa­tients, sig­nif­i­cant­ly im­prov­ing sur­vival when giv­en …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA